In a report released today, Mayank Mamtani from B.Riley Financial maintained a Hold rating on Vaxart (VXRT - Research Report), with a price target of $6.00. The company's shares opened today at $4.43.According to TipRanks, Mamtani is an analyst with an average return of -24.1% and a 27.48% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Novavax, Arrowhead Pharmaceuticals, and Altimmune.Currently, the analyst consensus on Vaxart is a Moderate Buy with an average price target of $6.50.
https://www.tipranks.com/news/blurbs/b-riley-financial-keeps-their-hold-rating-on-vaxart-vxrt?utm_source=advfn.com&utm_medium=referral
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more Vaxart Charts.
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more Vaxart Charts.